Vilin Bio Med (VILINBIO.NS) Stock Price

Vilin Bio Med Price

CLOSED
52.05
​
Market closed

Revenue at Vilin Bio Med has contracted by 18.3% per year over the past 2 years to 112.15 M INR. Earnings per share have declined at 54.6% per year over the last 2 years. For Vilin Bio Med, the net margin of 0.3% is broadly stable versus 1.0% a few years ago.

Vilin Bio Med stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vilin Bio Med business model & stock analysis

Vilin Bio Med Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2023-06-30. Vilin Bio Med Limited is an India-based company. The firm is engaged in the domestic business of manufacturing pharmaceutical products. Its product categories include solid oral dosage forms (beta and non-beta-lactam), oral liquids, external preparations, and dry powders. Its products include Cefixime, Azithromycin, Sulmtmicilline, Aceclofenac, Citicolin Sodium, Metformine, Pregabaline, Gabapentin, Diclofenac Sodium, Thiocolchicoside, Linseed Oil, Menthol, and Methyl Salcilate, among others. Its external preparations offer ointments along with similar products like creams, lotions, gels, and pates in certain formulations primarily designed to be applied to the skin. Its beta-lactam products are a group of medicines that are used to treat infections caused by some germs (bacteria and certain parasites). Its non-beta-lactam tablets and capsule products are generally used for general diseases like colds, flu, fever, anti-gastrological, antimalaria, and several other viral diseases.

Frequently asked questions about Vilin Bio Med

Converted at the current exchange rate, the Vilin Bio Med share trades at 0.49 EUR (52.05 INR).

The revenue cannot currently be calculated for Vilin Bio Med.

The profit cannot currently be calculated for Vilin Bio Med.

The P/E ratio cannot be calculated for Vilin Bio Med at the moment.

The P/S cannot be calculated for Vilin Bio Med currently.

The Eulerpool Quality Score for Vilin Bio Med is 1/10.

The ISIN of Vilin Bio Med is INE0L4V01013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Vilin Bio Med is VILINBIO.NS. The ticker symbol is used to trade Vilin Bio Med shares on the stock exchange.

Fair ValueTerminal
51.53 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jun 30, 2023
ISIN
INE0L4V01013
Cusip
Y938EJ107
Market capitalization
793.76 M INRSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
10.73
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.26 %
Last updated Nov 2, 2026, 3:05 AM

Vilin Bio Med Peer Group

Vilin Bio Med FIGI

VILINBIO:IN · BBG01H09GY54VILINBIO:IS · BBG01H09SSF3

All fundamentals and in-depth analysis of Vilin Bio Med

Our stock analysis for Vilin Bio Med stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vilin Bio Med. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.